The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

LONDON, England—New research has identified several high-risk variables associated with the need for a new permanent pacemaker after TAVI for aortic stenosis. None on the list are among the more ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

Balance athletic goals with arrhythmia risk: match the device model and sensor to the sport, and use stress testing to set detection zones and avoid inappropriate therapy.